Case Study: AIIM achieves efficient global trading and automated compliance with Enfusion

AIIM Investment Management has partnered with Enfusion to increase their global trading efficiency

AIIM is a Hong Kong–based long/short equity hedge fund that launched in April 2022 and trades across the US, EMEA and APAC. Because it works with multiple counterparties and faces differing regulatory reporting thresholds across jurisdictions, AIIM needed a platform to automate pre- and post-trade compliance, customize alerts and reporting, and give a single, timely view of portfolio and cash positions — needs it addressed with Enfusion’s trading and compliance platform.

Enfusion implemented customized portfolio views and reporting from a single data source, automated pre- and post-trade compliance rules, and direct connectivity to prime brokers for real-time stock locates. As a result, AIIM gained one consolidated portfolio view for CIO, trader and back office coordination, met regulatory reporting requirements in Europe and Asia, reduced time and cost from manual broker interactions, and improved cash monitoring and yield — delivering clear efficiency and operational benefits using Enfusion.

AIIM

Michelle Lim

Partner and COO